Year: 2025

🎓 Education

Dr. Lakizadeh began his academic journey at the University of Tehran, where he earned his Bachelor’s (2001–2005) and Master’s (2005–2007) degrees in Computer Science, focusing on bioinformatics and machine learning. He later completed his Ph.D. in Computer Engineering at Tarbiat Modares University (2011–2016), with research centered on machine learning, computational systems biology, and bioinformatics. 🎓📚

💼 Experience

Since 2008, Dr. Lakizadeh has served as an Assistant Professor at the University of Qom, contributing significantly to research in AI, multimedia, and medical imaging. He has mentored over 70 postgraduate students and spearheaded 30+ research publications. As the current Head of the Computer Engineering and IT Department, he oversees 1000+ students, academic programs, and research initiatives. 🏛️🧑‍🏫

🔬 Research Interest

Dr. Lakizadeh’s research interests include deep learning, computer vision, digital pathology, drug repurposing, anticancer peptide prediction, and Alzheimer’s detection. He is passionate about creating AI-driven solutions for real-world medical and pharmaceutical challenges. His interdisciplinary work integrates data from biology, medicine, and computer science to deliver impactful innovation. 💡🧠💊

🏅 Awards

While specific honors aren’t listed, Dr. Lakizadeh’s leadership of high-impact AI projects, numerous peer-reviewed publications, and influential role in academia highlight his excellence and recognition in the fields of computer science and bioinformatics. He is a highly respected figure in interdisciplinary AI research. 🏆📘

📚 Publications

PU-GNN: A Positive-Unlabeled Learning Method for Polypharmacy Side-Effects Detection, International Journal of Intelligent Systems, 2024.
Cited by: Multiple future studies in drug safety prediction.

Drug Repurposing Using Hypergraph Embedding, Journal of Computational Biology, 2024.
Cited by: Studies in computational drug discovery.

GADNN: Graph Attention-based Drug Association Method, Informatics in Medicine Unlocked, 2024.
Cited by: Research in bioinformatics and AI.

Detection of Polypharmacy Side Effects via CNN, Molecular Diversity, 2022.
Cited by: Pharmacological safety frameworks.

Drug-Drug Interaction via GNN, Scientific Reports, 2022.
Cited by: Advanced machine learning in pharma.

ASDvit: Autism Classification using Vision Transformer, Intelligence-Based Medicine, 2025.
Cited by: Pediatric AI diagnostic tools.

Early Diagnosis of Alzheimer’s Disease via ResNet50 and FSBi-LSTM, Informatica, 2025.
Cited by: Neuroscience AI literature.

Face Hallucination via GAN, Journal of Electrical Systems, 2024.
Cited by: Vision-based AI modeling.

Power-Efficient IoT Optimization, Journal of Electrical Systems, 2024.
Cited by: Industrial Internet of Things (IIoT) research.

🏆 Conclusion

Dr. Amir Lakizadeh demonstrates all the hallmark qualities of a Best Researcher Award recipient—innovation, productivity, leadership, and real-world impact. His work seamlessly bridges foundational AI with urgent healthcare and societal applications. With a few strategic steps toward global engagement and open dissemination, his already impressive profile could set a benchmark for excellence.

busra buran | Public transportation | Best Researcher Award

Published on 03/06/202503/06/2025 by Research Hypothesis

Dr. busra buran | Public transportation | Best Researcher Award

PhD, Istanbul Technical University, Turkey

Dr. Büşra Buran is an accomplished academic and professional leader in Management in Engineering, blending advanced research with practical innovation in public transportation systems. With over a decade of progressive leadership at IETT, Istanbul’s transportation authority, she has contributed significantly to strategy, innovation, and process optimization. Her expertise lies at the intersection of industrial engineering, strategic management, and digital transformation in public mobility. 🚍📊

Profile

🎓 Education

Dr. Büşra Buran holds a Ph.D. in Business Management Engineering from Istanbul Technical University (2018–2023), where she specialized in fuzzy logic applications and strategic decision-making in transportation. She completed her M.Sc. in Industrial Engineering at Galatasaray University (2010–2012) and a B.Eng. in Industrial Engineering at Yıldız Technical University (2007–2010). Her academic excellence is reflected in her consistent GPA above 3.4. 🎓📘

💼 Experience

With extensive experience at IETT, Dr. Buran currently serves as the Head of Strategy Development, leading strategic planning, KPI analysis, process optimization, and international collaboration. She has also managed service improvement, operation planning, and optimization of Istanbul’s Metrobus system. Her contributions have modernized Istanbul’s transport operations, blending academic knowledge with practical policy implementation. 🌐🚦

🔬 Research Interests

Her research revolves around strategic management in public transportation, fuzzy decision-making systems, transport optimization, and digital transformation. She is passionate about applying hybrid models to improve service quality and sustainability in urban mobility. 🧠📈

🏆 Awards

Dr. Büşra Buran has earned recognition for academic and professional excellence, including leadership roles and project management awards within IETT. She holds certifications in Project Management, Leadership and Innovation, and Quality Systems, underscoring her holistic leadership in engineering management. 🥇🏅

📚 Publications

🔗 PESTLE Analysis for Public Transportation: A Fuzzy Approach – Springer, 2024

🔗 Hybrid Fuzzy Approach for Bus Type Selection: IETT Case Study – Springer, 2023

🔗 Place of Informal Transportation in Public Transport – IJESA, 2023, Cited by 4 articles

🔗 Bus Type Selection with Fuzzy Approach – Systems and Soft Computing, 2023, Cited by 6

🔗 A Digital Business Model Framework – Proceedings Book, 2022

🔗 Business Model Evaluation with Fuzzy AHP – Expert Systems with Applications, 2022, Cited by 8

🔗 Public Transport Assessment with Spherical Fuzzy AHP – Springer, 2022

🔗 Sentiment Analysis During Covid-19 – Springer, 2021

🔗 Convergence Among Public Transport Business Models – Sustainability, 2021, Cited by 15

🔗 Modeling Quality of Bus Services – Pamukkale University Journal, 2017

✅ Conclusion

Dr. Büşra Buran is a highly competent and impactful researcher whose work significantly contributes to public transportation efficiency, strategic management, and applied fuzzy systems. With her strong academic background, robust publication record, and demonstrated leadership in strategic urban planning, she is a well-deserving candidate for the Best Researcher Award in the field of Engineering Management and Public Transportation Systems. 🏆🌟📚

Elie Azoulay | Medicine and Health Sciences | Hypothesis Achievement Award

Published on 03/06/202503/06/2025 by Research Hypothesis

Prof. Elie Azoulay | Medicine and Health Sciences | Hypothesis Achievement Award

Intensive care medicine department, at Saint Louis hospital, France.

Prof. Elie Azoulay is a distinguished French intensivist and the Director of the Critical Care Department at Hôpital Saint-Louis in Paris. He is renowned for his pioneering work in managing critically ill immunocompromised patients. As the founder and director of Nine-I, a multinational group focusing on immunocompromised patients, and co-director of the Famirea Study Group, he has significantly advanced research in intensive care medicine. His leadership extends to founding GRRR-OH, a French multicenter group dedicated to critically ill immunocompromised patients. Prof. Azoulay’s academic contributions are further highlighted by his role as Editor-in-Chief of Intensive Care Medicine from 2012 to 2018, during which the journal’s impact factor rose from 5 to 18. He has also served as President of the European Society of Intensive Care Medicine and is an advisory board member for The Lancet Respiratory Medicine.

Professional Profile

ORCID

🎓 Education

Prof. Azoulay’s academic journey began at Paris VI University (Sorbonne), where he earned his MD in 1991. He furthered his expertise with a Master’s degree in Respiratory Physiology from Paris XII University in 1995. In 2002, he completed his PhD in Respiratory Physiology at Paris VII University (Descartes). His commitment to advancing medical science led him to obtain Habilitation to Conduct and Lead Research from Paris VII University in 2003. Additionally, he holds a University Diploma in Critical Care Management of Immunocompromised Patients from Université Paris Cité, obtained in 2012. His educational background underscores his dedication to both clinical excellence and research innovation in intensive care medicine.

💼 Experience

Prof. Azoulay has an extensive career in intensive care medicine, beginning as a medical intern at Bichat-Claude Bernard Hospital in Paris. He has held significant positions, including serving as a professor of medicine at Paris VII University since 2004. His leadership roles encompass founding and directing several research groups, such as GRRR-OH and Nine-I, focusing on critically ill immunocompromised patients. He has been actively involved in various committees, including the Strategy Committee of the Hospital Group in Paris and the Medical Staffing Group. Prof. Azoulay’s editorial contributions are notable, having served as Editor-in-Chief of Intensive Care Medicine and as an associate editor for prominent journals like Critical Care Medicine and American Journal of Respiratory and Critical Care Medicine. His work has significantly influenced the field of intensive care medicine, particularly concerning immunocompromised patients.link.springer.com

🔬 Research Interests

Prof. Azoulay’s research primarily focuses on the management of critically ill immunocompromised patients, particularly those with hematological malignancies or undergoing immunosuppressive therapies. His work addresses acute respiratory failure, infections, and the psychosocial impact on patients and their families. He has led multicenter studies on the outcomes of intensive care in immunocompromised patients and the prevalence of ICU-related conflicts. His research also delves into the prevention of mental health disorders in ICU settings and the development of strategies to support family members of critically ill patients. Through his interdisciplinary approach, Prof. Azoulay aims to enhance patient care and outcomes in intensive care units.

🏆 Awards

Prof. Azoulay’s exceptional contributions to intensive care medicine have been recognized with several prestigious awards. In 2021, he received the International KJF Award, acknowledging his significant impact on critical care research. His editorial leadership has been instrumental in elevating the impact factor of Intensive Care Medicine. Additionally, his involvement in various international research initiatives has garnered him recognition from global medical communities. These accolades reflect his dedication to advancing the field of intensive care medicine and improving patient outcomes worldwide.rigshospitalet.dk

📚 Top Noted Publications

Prof. Azoulay has authored over 1,200 publications, contributing extensively to the field of intensive care medicine. Notable among his works is the 2019 study on acute respiratory failure in immunocompromised adults, published in The Lancet Respiratory Medicine, which has been cited over 1,000 times. His 2022 research in JAMA on post-traumatic stress symptoms in family members of ICU patients has also garnered significant attention. These publications reflect his commitment to addressing both clinical and psychosocial aspects of critical care. His work continues to influence practices and policies in intensive care units globally.

📌 1. Outcomes in Immunocompromised Patients with Acute Hypoxemic Respiratory Failure Treated by High-Flow Nasal Oxygen

Journal: Intensive Care Medicine
Date: April 2025
DOI: 10.1007/s00134-025-07890-5
Authors: Elie Azoulay, Mélanie Métais, Virginie Lemiale, Djamel Mokart, et al.
Summary:
This multicenter study evaluates the effectiveness and outcomes of high-flow nasal oxygen (HFNO) in immunocompromised patients with acute hypoxemic respiratory failure (AHRF). Key findings suggest that early initiation of HFNO is associated with improved survival, particularly in hematologic patients. It supports HFNO as a frontline noninvasive respiratory support strategy in this vulnerable population.

📌 2. Correction: HELLO – A Protocol for a Cluster RCT to Enhance ICU Team Cohesion

Journal: Intensive Care Medicine Experimental
Date: January 2025
DOI: 10.1186/s40635-024-00702-y
Authors: Elie Azoulay, Nancy Kentish Barnes, Sheila Nainan Myatra, et al.
Summary:
This correction addresses minor protocol amendments in the HELLO trial, aimed at improving interpersonal relationships and teamwork among ICU professionals. The original trial focuses on evaluating whether targeted interventions can reduce burnout and enhance job satisfaction, thus improving team-based care delivery.

📌 3. Lack of Up-to-Date Studies and Data Conversion May Lead to Biased Results: A Response to Wang et al.

Journal: Critical Care
Date: December 2024
DOI: 10.1186/s13054-024-05223-4
Authors: Ali Ait Hssain, Amir Vahedian-Azimi, Elie Azoulay, et al.
Summary:
A scholarly rebuttal to a prior publication, emphasizing the importance of timely and context-relevant data in intensive care research. The authors argue that reliance on outdated studies and improper data interpretation can introduce significant bias in clinical decision-making and policy formulation.

📌 4. Complement System Activation: Bridging Physiology, Pathophysiology, and Therapy

Journal: Intensive Care Medicine
Date: November 2024
DOI: 10.1007/s00134-024-07611-4
Authors: Elie Azoulay, Julien Zuber, Djillali Annane, et al.
Summary:
A comprehensive review of complement system activation in critically ill patients, exploring its dual role in host defense and inflammatory damage. The paper highlights novel therapeutic targets and the need for individualized modulation in conditions like sepsis and ARDS.

📌 5. Treatment of Invasive Pulmonary Aspergillosis and Candidiasis in ICU Patients

Journal: American Journal of Respiratory and Critical Care Medicine
Date: November 2024
DOI: 10.1164/rccm.202410-2045ST
Authors: Oleg Epelbaum, Elie Azoulay, et al.
Summary:
This ATS Clinical Practice Guideline outlines evidence-based recommendations for diagnosing and treating invasive fungal infections in ICU settings. It provides a framework for empirical and targeted antifungal therapy, addressing the rising concern of fungal superinfections in critical care.

Conclusion

Professor Elie Azoulay is an outstanding candidate for the Research for Hypothesis Achievement Award. His pioneering work in the intensive care management of immunocompromised patients, groundbreaking contributions to mental health in ICU survivors and their families, and leadership in multicenter, hypothesis-driven trials position him as a globally respected clinician-scientist. His profile aligns deeply with the intent of the award—translating complex hypotheses into high-impact, patient-centered outcomes.

Oluwatobi Otun | Biology and Life Sciences | Best Researcher Award

Published on 03/06/202503/06/2025 by Research Hypothesis

Dr. Oluwatobi Otun | Biology and Life Sciences | Best Researcher Award

Postdoctoral Reseacher, at University of the Witwatersrand (WITS), South Africa.

Dr. Oluwatobi Sarah Otun is a distinguished postdoctoral fellow at the University of the Witwatersrand’s Protein Structure-Function Research Unit in Johannesburg, South Africa. With a robust academic foundation, she holds a Ph.D. in Life Sciences from the University of South Africa (2020), an M.Sc. in Life Sciences (2015), and a B.Sc. in Microbiology from Lagos State University, Nigeria (2007). Her research spans microbiology, plant science, and molecular biology, focusing on protein biochemistry and omics technologies. Dr. Otun has authored over 15 peer-reviewed publications and has several articles in review. She actively mentors postgraduate students and contributes to various scientific journals as a reviewer. Her interdisciplinary approach and dedication to scientific advancement have established her as a prominent figure in her field. 🌱🔬📚weblogoa.com+1scitcentralconferences.com+1

Professional Profile

ORCID

Education

Dr. Otun’s academic journey commenced with a B.Sc. in Microbiology from Lagos State University, Nigeria, where she investigated the survival of pathogens in traditional beverages. She then pursued an M.Sc. in Life Sciences at the University of South Africa, focusing on the microbiological and nutritional qualities of leafy vegetables. Her doctoral research delved into the transcriptomic, proteomic, and metabolomic profiling of Sclerotinia sclerotiorum, a phytopathogenic fungus, earning her a Ph.D. in Life Sciences in 2020. Her educational background laid a solid foundation for her interdisciplinary research endeavors. 🎓📘🧬weblogoa.com

Experience

Dr. Otun’s professional trajectory includes significant roles in research and clinical settings. She currently serves as a postdoctoral fellow at the University of the Witwatersrand, focusing on protein structure-function analysis and omics applications in pathogen studies. Previously, she worked as a microbiology researcher at the Council for Scientific and Industrial Research (CSIR) in Pretoria, South Africa, contributing to various scientific projects. Additionally, she gained clinical experience as a medical laboratory technician at Ayodele Medical Centre in Lagos, Nigeria. These positions have enriched her research perspective, blending theoretical knowledge with practical applications. 🔬🧪👩‍🔬

Research Interests

Dr. Otun’s research interests encompass several key areas:

Protein structure-function analysis of microbial and plant proteins.
Application of omics technologies (transcriptomics, proteomics, metabolomics) in pathogen studies.
Cancer research, focusing on therapeutic targets and natural compounds.
Investigation of antimicrobial resistance mechanisms in ESKAPE pathogens.
Utilization of 3D cell culture models for cancer and drug response studies.
Engineering natural product biosynthesis for pharmaceutical applications.
Structure-based drug design using molecular docking and simulation tools.
Biotechnology-driven solutions for sustainable agriculture and food safety.
Her interdisciplinary approach aims to bridge gaps between microbiology, biotechnology, and medicine. 🧬🧪🌿weblogoa.com+1scitcentralconferences.com+1

Awards

Dr. Otun’s exceptional contributions to science have been recognized through several prestigious awards:

2023: Asia’s Outstanding Researcher Award by the Asia Research Awards, in association with Times of Research and the World Research Council, at ASTRA 2023.
2025: Provisional Selection for Best Researcher Award by the International Research Hypothesis Excellence Award, recognizing her recent publication on muscadine grape extracts in cancer treatment.
2025: UCL-Wits Preclinical 3D Modeling Team Science Award, awarded by the UCL-Wits University Strategic Partnership Platform for a meritorious project.
These accolades underscore her commitment to advancing scientific knowledge and innovation. 🏆🌍🔬

Top Noted Publications

Dr. Otun has an extensive publication record in renowned scientific journals

Otun, S., & Ntushelo, K. (2020).
Proteomic analysis of the phytogenic fungus Sclerotinia sclerotiorum.
Journal of Chromatography B, 1144, 122053.
DOI: 10.1016/j.jchromb.2020.122053

Published in volume 1144 of Journal of Chromatography B.
Article number: 122053 (often journals use article numbers instead of page ranges).

2. Mbovane, M.M.S., Gangireddygari, V.S.R., Otun, O.S., & Ntushelo, K. (2021).
Phylogenetic Analysis of Selected Genes of Pectobacterium carotovorum Subsp. Brasiliense.
SSRN (preprint server).
DOI: 10.2139/ssrn.3992372

This is a preprint hosted on SSRN (Social Science Research Network).
No volume or issue because it’s a preprint.

3. Otun, S.O., Achilonu, I., & Ntushelo, K. (2022).
Proteomics analysis of the phytopathogenic fungus Sclerotinia sclerotiorum: a narrative review.
Journal of Bio-XResearch, 5(3), 112–117.
DOI: 10.1097/JBR.0000000000000130

Volume 5, Issue 3, pages 112 to 117.

4. Pooe, K., Thulo, M., Makumbe, H., Akumadu, B., Otun, O., Aloke, C., & Achilonu, I. (2022).
Biophysical description of Bromosulfophthalein interaction with the 28-kDa glutathione transferase from Schistosoma japonicum.
Molecular and Biochemical Parasitology, 252, 111524.
DOI: 10.1016/j.molbiopara.2022.111524

Volume 252, article number 111524.

5. Otun, S.O., & Ntushelo, K. (2024).
A data catalogue of alcohol dehydrogenases in the genome of a tissue macerating Pectobacterium brasiliense isolated from potato in South Africa.
Data in Brief, 52, 109918.
DOI: 10.1016/j.dib.2023.109918 (likely based on journal’s DOI pattern)

Volume 52, article number 109918.

Conclusion

Dr. Oluwatobi Sarah Otun exemplifies the qualities of an outstanding researcher deserving of the Best Researcher Award. Her strong academic foundation, impressive research output, innovative work with societal relevance, and active professional engagement position her as a leading candidate. While minor enhancements in international collaboration and impact metrics reporting could further bolster her profile, her contributions to molecular biology, biotechnology, and cancer research clearly demonstrate her excellence and significant impact in her field.

Wanamina Bostan Ali | Business Administration | Best Researcher Award

Published on 03/06/202503/06/2025 by Research Hypothesis

Assist. Prof. Dr. Wanamina Bostan Ali | Business Administration | Best Researcher Award

Assistan Professor, Prince of Songkla University, Thailand

Dr. Wanamina Bostan Ali is an accomplished Assistant Professor in the Department of Business Administration at Prince of Songkla University, Thailand 🇹🇭. With extensive experience in academia and industry across several countries, she has built a remarkable profile in management education, international business, and innovation. Her leadership as Director of the MBA International Program and involvement in sustainable and digital business research reflect her dedication to knowledge advancement and student development. 🌏📚

Profile

🎓 Education

Dr. Bostan Ali earned her Doctor of Business Administration (D.B.A.) from Victoria University, Melbourne 🇦🇺, specializing in Management. She also holds an M.B.A. in International Business and a B.A. in Public Relations and Journalism from the University of Southern Queensland, Australia. Her academic path reflects a strong interdisciplinary foundation combining business, communication, and strategic development. 🎓🌐

💼 Experience

With over 15 years of diverse work experience across academia and corporate sectors, Dr. Ali has served as a Lecturer and Assistant Professor in Thailand, Australia, and Malaysia. Notable roles include her tenure at Victoria University, Dusit Thani College, and Broadway Digital Media. She has held administrative leadership roles, including Assistant Dean and Director of International MBA Programs, showcasing her commitment to academic excellence and innovation. 🌍🏢📈

🔬 Research Interest

Dr. Ali’s research spans service innovation, e-business, ESG performance, Halal tourism, and behavioral studies in digital services. She actively explores the intersections of sustainability, entrepreneurship, and technology adoption in Southeast Asia. Her multidisciplinary research addresses real-world business and societal challenges, especially in the MICE (Meetings, Incentives, Conferences, and Exhibitions) industry. 🌿💼🧠

🏆 Awards

Dr. Ali is recognized for her scholarly contributions and leadership in management education. She is a member of the Global Association for MSMEs and SDGs Research in Developing Countries (2023), affirming her role in driving sustainable development goals through academic research and global collaboration. 🌟🌐

📚 Publications

📄 In Problems and Perspectives in Management (2023), she co-authored “Factors influencing job stress: Evidence from tellers,” cited by 10+ articles.
📄 Her work “Financial Factors Influencing ESG Ratings” in Cogent Business & Management (2022) is indexed in SCOPUS and cited by 15+ articles.
📄 She published “What Causes Behavioral Intention in Online Food Delivery” in Journal of Positive School Psychology (2022), cited by 12+.
📄 In ABAC Journal (2022), she authored “Customer Trust in Latex Glove Industry,” exploring COVID-19’s impact on consumer behavior, cited by 9+.
📄 Her 2019 article on e-business tech adoption in Journal of Management Sciences remains a key reference for Thai entrepreneurs.
📄 “Halal Hotel Industry in Muslim-majority vs Minority Countries” (Journal of Halal Industry & Services, 2018) is widely cited in tourism research.
📄 “Perceived Value & TAM in Tech Use” (Psychology and Education, 2021) has gained 14+ citations.
📄 She co-authored “Flexible Working Hours During COVID-19” in Philosophical Readings (2021), cited by 10+.

✅ Conclusion

Dr. Wanamina Bostan Ali is a strong candidate for the Best Researcher Award, especially in the fields of sustainable management, Islamic tourism, and business innovation. His prolific output, broad teaching portfolio, and leadership roles highlight his dedication and versatility in research and education. While a sharper focus on impactful publishing and international collaboration could further strengthen his case, his existing achievements firmly position him as a deserving nominee.

Badr Machkour | Artificial Intelligence | Best Researcher Award

Published on 03/06/202503/06/2025 by Research Hypothesis

Dr. Badr Machkour | Artificial Intelligence | Best Researcher Award

Professor, Faculty of Legal, Economic and Social Sciences, Morocco

Dr. Badr Machkour is a Moroccan researcher and academic with deep expertise in economics, finance, and digital transformation. Currently holding a Ph.D. in Economic and Management Sciences, he has contributed to multiple domains including Industry 4.0, financial digitalization, and educational innovation. With a robust blend of academic and consulting experience, Dr. Machkour bridges theory and practice to drive impactful research. 🌐📊

Profile

🎓 Education

Dr. Machkour holds a Doctorate in Economic and Management Sciences (2018–2023) from the FSJES of Agadir. His academic foundation includes a degree in Audit and Management Control from ENCG Agadir (2014–2017), post-preparatory classes in Economics and Commerce (2012–2014), and a Mathematics Baccalaureate (2011–2012). His diverse training forms a strong base for multidisciplinary research. 📚🧠

💼 Professional Experience

Dr. Machkour has extensive experience as a financial auditor, consultant, and trainer. He currently serves as a trainer at the Cité des Métiers et des Compétences (OFPPT), delivering finance and management programs. His previous roles span auditing and consulting at prominent firms like Augeco, MAZARS Maroc, and Agadir Conseil, involving sectors from agriculture to banking. 🏢💼📈

🔬 Research Interests

His research explores the intersection of Industry 4.0, digital banking solutions, customer experience, AI in education, and entrepreneurship. Dr. Machkour is particularly interested in how technology transforms economic relationships, pedagogical structures, and corporate strategies. 🤖📱🏫

🏆 Awards & Honors

While specific awards are not listed, Dr. Machkour’s work has been featured in indexed journals and cited internationally — notably his highly cited paper on Industry 4.0’s implications in finance. His academic contributions reflect both quality and influence. 🥇🌍

📑 Publications

Industry 4.0 and its Implications for the Financial Sector, Procedia Computer Science, 2020 — Cited by 151 🏦

The Rise of Artificial Intelligence in Educational Management: A Prospective Analysis on the Role of the Virtual Educational Director, Procedia Computer Science, 2025 🧠

Internet of Things in Education: Transforming Learning Environments, Enhancing Pedagogy, and Optimizing Resource Management, Data and Metadata, 2024 🏫

L’impact de l’adoption des solutions digitales sur la relation banque-client, Revue Française d’Economie et de Gestion, 2024 — Cited by 2 📲

Les facteurs d’adoption des solutions digitales bancaires par les consommateurs marocains, IJAFAME, 2022 — Cited by 1 📱

The Uses of Connected Objects and Their Influence on the Customer Experience, Test Engineering and Management, 2020 — Cited by 1 🌐

Etude exploratoire du développement de l’esprit Entrepreneurial et des compétences Entrepreneuriales auprès des étudiants au Maroc, Alternatives Managériales Economiques, 2024 👨‍🎓

Entrepreneurship 4.0 and Success Factors in the Context of Industry 4.0: A literature review, African Scientific Journal, 2024 🚀

✅ Conclusion

Overall, Dr. Badr Machkour is a promising and accomplished researcher whose work bridges digital innovation and economic practice with scholarly insight. His growing citation record, topical relevance, and interdisciplinary reach make him a strong candidate for the Best Researcher Award. With continued international engagement and broader collaborative networks, his impact is poised to grow even further. 🌍📈

Ghulam Muhayyudin Chattha | Nanotechnology | Best Researcher Award

Published on 03/06/202503/06/2025 by Research Hypothesis

Mr. Ghulam Muhayyudin Chattha | Nanotechnology | Best Researcher Award

Mr. Ghulam Muhayyudin Chattha, at Federal University of Rio Grande do Sul (UFRGS), Brazil.

Ghulam Muhayyudin Chattha is a Pakistani pharmaceutical scientist born on December 9, 1998, in Porto Alegre, Brazil. Currently pursuing a Master’s in Pharmaceutical Sciences at Universidade Federal do Rio Grande do Sul (UFRGS), Brazil, he holds a Pharm-D degree from the University of Sargodha, Pakistan. His academic journey reflects a commitment to advancing pharmaceutical sciences through rigorous education and research. Chattha’s work bridges international perspectives, contributing to the global discourse on pharmaceutical innovations.

Professional Profile

ORCID

Education

Chattha’s educational foundation in pharmaceutical sciences began with his secondary education in Gujranwala, Pakistan, followed by pre-medical studies at Punjab College of Commerce. He earned his Pharm-D degree from the University of Sargodha, achieving a CGPA of 3.55/4. Currently, he is pursuing a Master’s in Pharmaceutical Sciences at UFRGS, Brazil, focusing on advanced drug delivery systems and nanotechnology. His academic path showcases a dedication to acquiring comprehensive knowledge in pharmaceutical sciences.

Experience

Chattha’s professional experience encompasses roles in academia and clinical pharmacy. As a lecturer at Ahmad College of Pharmacy, he delivered lectures and assisted students during laboratory sessions, fostering a scientific approach to learning. His internships at Dispensary Pharmacy and DHQ Teaching Hospital involved advising patients on medication use and maintaining pharmacy operations. These experiences have honed his practical skills in patient care and pharmaceutical education.

Research Interests

Chattha’s research interests lie in the development of innovative drug delivery systems, particularly focusing on nanotechnology. His work explores nanoparticle-mediated therapies, including photothermal and photodynamic treatments, aiming to enhance the efficacy and safety of antifungal and anticancer drugs. He is also investigating the safety profiles of surfactants in nano-formulations, contributing to the advancement of safer pharmaceutical products.

Awards

Throughout his academic and professional journey, Chattha has been recognized for his contributions to pharmaceutical sciences. He has received accolades for his research presentations at international conferences, including the Third International Innovation in Pharmacy Conference in 2022. These awards underscore his commitment to advancing pharmaceutical knowledge and his active participation in the scientific community.

Top Noted Publications

Chattha has contributed to several peer-reviewed publications in reputable journals. His recent work includes:

1. Nanoparticle-Mediated Photothermal Therapy and Photodynamic Therapy: A Novel Strategy for Antifungal Drug Delivery and Treatment

Status: Accepted (2025)
Key Details:

Focus: Combines photothermal therapy (PTT) and photodynamic therapy (PDT) using nanoparticles (NPs) for the treatment of fungal infections.
Innovation: Dual-action therapy enhances antifungal efficacy while minimizing systemic toxicity.
Mechanism:
- PTT: Converts light energy into localized heat to kill fungal cells.
- PDT: Produces reactive oxygen species (ROS) upon light activation to damage fungal cell structures.
Nanoparticles used: Gold NPs, carbon-based NPs, and porphyrin-loaded nano-formulations.
Advantages: Targeted delivery, minimal resistance development, reduced dosage and side effects.
Applications: Treating resistant fungal infections in clinical settings, especially in immunocompromised patients.

2. Safety Concerns of Surfactants Used in Various Types of Nano-formulations: A Comprehensive Review

Status: Submitted (2025)
Key Details:

Focus: Reviews the toxicity and biocompatibility of surfactants used in nano-formulations across pharmaceutical, cosmetic, and food industries.
Surfactants covered: Tween, Span, SDS, Pluronic, and bile salts.
Concerns Addressed:
- Cytotoxicity and immunogenicity.
- Effects on biodistribution and clearance of nanoparticles.
- Interaction with biological membranes and long-term exposure risks.
Recommendations: Emphasizes the need for safer, biodegradable surfactants and standardized toxicity assessments.
Outcome: Proposes guidelines for regulatory screening and clinical translation of nano-formulated products.

3. Nanorobots: An Innovative Approach for DNA-Based Cancer Treatment

Published: 2023
Key Details:

Focus: Discusses the design and functionality of DNA-based nanorobots for targeted cancer therapy.
Mechanism:
- Uses DNA origami and molecular logic gates to recognize tumor-specific markers.
- Nanorobots deliver therapeutic payloads (e.g., siRNA, chemotherapeutics) directly into cancer cells.
Key Features:
- Biocompatibility and programmability of DNA structures.
- Tumor-targeting via aptamers or antibody-conjugated nanorobots.
Preclinical Results: Demonstrated efficient tumor regression in murine models with minimal off-target effects.
Future Prospects: Customizable platforms for precision oncology and potential integration with CRISPR or immunotherapy strategies.

Conclusion

Ghulam Muhayyudin Chattha exhibits clear potential and emerging excellence as a pharmaceutical researcher. His active publication record, diverse research focus, and international exposure support his candidacy for the Best Researcher Award. While there is room for growth in terms of deeper research engagement and language fluency, his trajectory shows dedication, multidisciplinary skill development, and consistent academic and professional improvement.

Han Zhang | Sustainability | Best Researcher Award

Published on 03/06/202503/06/2025 by Research Hypothesis

Assoc. Prof. Dr. Han Zhang | Sustainability | Best Researcher Award

Associate Professor, Qingdao University, China

Dr. Han Zhang is an esteemed academic currently serving as an Associate Professor at the Business School of Qingdao University, China 🇨🇳. With a Ph.D. in Applied Economics and postdoctoral research in Management Science and Engineering, Dr. Zhang contributes significantly to contemporary economic thought, especially in urban and rural development, green innovation, and defense economics. His scholarly pursuits are marked by interdisciplinary depth and practical policy relevance 🌏📊.

Profile